Coverage of OHSU’s 2024 commencement ceremony, where more than 1,050 degrees and certificates were awarded, features soon-to-be PA graduate Mandy Paolo, who plans to help rural Oregonians access quality primary care, and Ali Sultan, D.M.D., who is following in his father’s footsteps by becoming a dentist.

In a story about PDXLAN, a twice-yearly video gaming party in Clark County, Washington, that has raised funds to provide gaming equipment to children who are undergoing cancer care at OHSU Doernbecher Children’s Hospital, Rebekah Coles says, “These funds and other donations have provided gaming systems, games, tablets, handheld device and more."

An OHSU collaboration with researchers at the University of South Florida is leveraging AI to create advanced brain maps that may help better understand Alzheimer’s disease.

Alexandra Zimmer, M.D., is one of three medical experts interviewed for a HealthCentral article detailing the different breast cancer medications available for patients.

Bethany Samuelson Bannow, M.D., shares insight with Healthy Women about research of modern menstrual products: “The important thing to note is the distinction between medical diagnostic tools and products used for other purposes. So if I’m going to check someone for thyroid disease, I’m going to send them to a lab and do a test that was specifically created for that purpose. But when we are diagnosing heavy periods, we are really dependent on reports of what patients are using.”

Research teams at OHSU’s Center for Mental Health Innovation were awarded $16.4 million to leverage machine learning to improve prediction and diagnosis of youth mental health conditions.

Research in nonhuman primates shows a cytomegalovirus-based vaccine platform developed by Klaus Früh, Ph.D., and colleagues is responsive to common cancer antigens and can identify and attack cancer cells. Früh says, “Having a vaccine that can elicit cancer-specific T cells that act as an immune shield continuously patrolling your body and that would protect you for the rest of your life is just really exciting.”

Research in nonhuman primates shows a cytomegalovirus-based vaccine platform developed by Klaus Früh, Ph.D., and colleagues is responsive to common cancer antigens and can identify and attack cancer cells. Früh says, “Having a vaccine that can elicit cancer-specific T cells that act as an immune shield continuously patrolling your body and that would protect you for the rest of your life is just really exciting.”

24/7 Sports publishes an interview with University of Oregon football coach Dan Lanning, who participated in a charity golf tournament on behalf of the OHSU Knight Cancer Institute. Lanning says, “I'm working with OHSU and the Knight Cancer Institute. One of the reasons it sticks out to me and my family is what they do for our community in Oregon, but my wife is also a cancer survivor. It certainly means a lot to us to be able to contribute to cancer research and try our best to find a cure.”

Flavio Rocha, M.D., is on OPB’s “Think Out Loud” to discuss what’s driving the trend in younger people being diagnosed with cancer, how clinicians and researchers are responding, and what the public can do; he says: “Since 1991, cancer mortality has actually decreased by 33%. A lot of that is due to all the work that’s been done in the research space and the clinical space. Overall, I think we are making progress against cancer. What we’re seeing in younger folks, we’re trying to figure out why that’s the case.”